ESR1 and neoplasm: These observations suggest that cell-free miR200s are not only promising biomarkers in the non-invasive diagnostics of ovarian cancer but might provide information about the pathophysiology of the tumor cells as well (e.g., ERα expression and estrogen responsiveness).